摘要:
oup.com
annalsofoncology.org
sci-hub.se 参考文章(29)
G. E. Winter, D. L. Buckley, J. Paulk, J. M. Roberts, A. Souza, S. Dhe-Paganon, J. E. Bradner, Phthalimide conjugation as a strategy for in vivo target protein degradation Science. ,vol. 348, pp. 1376- 1381 ,(2015) , 10.1126/SCIENCE.AAB1433
David Cook, Dearg Brown, Robert Alexander, Ruth March, Paul Morgan, Gemma Satterthwaite, Menelas N. Pangalos, Lessons learned from the fate of AstraZeneca's drug pipeline: a five-dimensional framework Nature Reviews Drug Discovery. ,vol. 13, pp. 419- 431 ,(2014) , 10.1038/NRD4309
John P A Ioannidis, Sander Greenland, Mark A Hlatky, Muin J Khoury, Malcolm R Macleod, David Moher, Kenneth F Schulz, Robert Tibshirani, Increasing value and reducing waste in research design, conduct, and analysis The Lancet. ,vol. 383, pp. 166- 175 ,(2014) , 10.1016/S0140-6736(13)62227-8
Carol Babij, Yihong Zhang, Robert J. Kurzeja, Anke Munzli, Amro Shehabeldin, Manory Fernando, Kim Quon, Paul D. Kassner, Astrid A. Ruefli-Brasse, Vivienne J. Watson, Flordeliza Fajardo, Angela Jackson, James Zondlo, Yu Sun, Aaron R. Ellison, Cherylene A. Plewa, Miguel Tisha San, John Robinson, John McCarter, Ralf Schwandner, Ted Judd, Josette Carnahan, Isabelle Dussault, STK33 Kinase Activity Is Nonessential in KRAS-Dependent Cancer Cells Cancer Research. ,vol. 71, pp. 5818- 5826 ,(2011) , 10.1158/0008-5472.CAN-11-0778
C. Glenn Begley, Lee M. Ellis, Drug development: Raise standards for preclinical cancer research Nature. ,vol. 483, pp. 531- 533 ,(2012) , 10.1038/483531A
G. Sinha, Careers In Biotech and Pharma: The Right Fit Science. ,vol. 316, pp. 619- 622 ,(2007) , 10.1126/SCIENCE.316.5824.619
Paul Glasziou, Douglas G Altman, Patrick Bossuyt, Isabelle Boutron, Mike Clarke, Steven Julious, Susan Michie, David Moher, Elizabeth Wager, Reducing waste from incomplete or unusable reports of biomedical research The Lancet. ,vol. 383, pp. 267- 276 ,(2014) , 10.1016/S0140-6736(13)62228-X
William Pao, Vincent A Miller, Katerina A Politi, Gregory J Riely, Romel Somwar, Maureen F Zakowski, Mark G Kris, Harold Varmus, Acquired Resistance of Lung Adenocarcinomas to Gefitinib or Erlotinib Is Associated with a Second Mutation in the EGFR Kinase Domain PLoS Medicine. ,vol. 2, pp. e73- ,(2005) , 10.1371/JOURNAL.PMED.0020073
Christine M. Lovly, Johannes M. Heuckmann, Elisa de Stanchina, Heidi Chen, Roman K. Thomas, Chris Liang, William Pao, Insights into ALK-Driven Cancers Revealed through Development of Novel ALK Tyrosine Kinase Inhibitors Cancer Research. ,vol. 71, pp. 4920- 4931 ,(2011) , 10.1158/0008-5472.CAN-10-3879
Michael S. Kinch, Austin Haynesworth, Sarah L. Kinch, Denton Hoyer, An overview of FDA-approved new molecular entities: 1827–2013 Drug Discovery Today. ,vol. 19, pp. 1033- 1039 ,(2014) , 10.1016/J.DRUDIS.2014.03.018